Because these medications target different body systems and use distinct chemical pathways, direct pharmacological conflicts are uncommon
(n=64,189.) Del Ponte B, Santos IS, Tovo Rodrigues L, et al
DeFronzo said a glucagon-like peptide 1 receptor agonist (GLP-1 RA) will correct six of the disturbances present in Type 2 diabetes individuals, sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment corrects three of the metabolic abnormalities, and pioglitazone fixes four of the problems with some overlap with the GLP-1 RAs and SGLT2i
If you experience hypoglycaemia (low blood sugar), take 15-20g of fast-acting carbohydrate (such as glucose tablets, fruit juice, or sugary drinks), recheck your glucose after 15 minutes, and repeat if necessary
Urol Nephrol 2001